(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 18.07% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.74%.
Axogen's revenue in 2025 is $214,709,000.On average, 12 Wall Street analysts forecast AXGN's revenue for 2026 to be $12,170,749,621, with the lowest AXGN revenue forecast at $11,345,160,648, and the highest AXGN revenue forecast at $12,785,098,511. On average, 10 Wall Street analysts forecast AXGN's revenue for 2027 to be $14,262,856,650, with the lowest AXGN revenue forecast at $13,406,365,744, and the highest AXGN revenue forecast at $14,969,450,118.
In 2028, AXGN is forecast to generate $16,258,568,095 in revenue, with the lowest revenue forecast at $15,621,158,061 and the highest revenue forecast at $16,736,856,232.